CHUM, Terry Fox Research Institute Launch Prostate Cancer Biomarker Study
July 25, 2012
CHUM, Terry Fox Research Institute Launch Prostate Cancer Biomarker Study
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Prostate Cancer MDx Competition Heating Up; New Data from Genomic Health, Myriad
May 15, 2013 / Pharmacogenomics Reporter - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Continuing Revenue Growth in Third Quarter, Myriad Keeps Focus on Diversifying MDx Product Portfolio
May 8, 2013 / Pharmacogenomics Reporter - With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise
May 8, 2013 / Pharmacogenomics Reporter - Researchers Devise 'Genetic Correction' to Improve PSA Test Ability to Gauge Prostate Cancer Risk
May 1, 2013 / Pharmacogenomics Reporter